The Ministry of Health has released this Wednesday the review of the Rare Diseases Strategy of the National Health System (SNS), with the aim of strengthening care coordination and bolstering cohesion and equity in care for affected people.
"The update strengthens coordination between professionals, centers, and care levels. It also improves cohesion, because we need to work together and move in the same direction across the entire National Health System, and equity, to reduce differences in access and care opportunities," the coordinator of the Rare Diseases Strategy and head of the area of the General Subdirectorate for Care Quality of the Ministry of Health, Carla Alejandra Dueñas, explained during the presentation.
The Rare Diseases Strategy of the SNS was approved for the first time in 2009 and was reviewed in 2014. In 2024, an evaluation of its implementation was carried out and, based on its conclusions, a new update was promoted, which received the go-ahead from the Interterritorial Council of the SNS last October.
"The approval of this new strategy marks the start of a new stage. The real challenge now is to turn all this work into concrete actions and real improvements for patients and their families. We will continue working to promote cooperation among the different agents involved and to evaluate the progress of the strategy," stated the General Subdirector for Care Quality of the Ministry of Health, María R. Fernández.
This review has been made possible thanks to the involvement of more than 70 professionals, with the participation of the autonomous communities and INGESA, scientific societies, patient associations, expert individuals and professionals from different disciplines, as well as various units and bodies of the Ministry of Health itself.
"It is a strategy that has had the support of the Interterritorial Council, despite the fact that its approval took place at a time marked by the electoral call. It is not a strategy that belongs to the Ministry of Health, but to the set of the dozens of people who have participated in the different working groups," the Secretary of State for Health, Javier Padilla, highlighted.
Within this framework, Padilla has highlighted the key role of neonatal screening within the strategy. He has recalled that at the beginning of the legislature the service portfolio included seven diseases and that, by the end of the same, the forecast is that it will stand at between 22 and 25 pathologies, depending on the criterion used to count the screened diseases.
Six priority lines of action
The update of the Strategy has been structured around six lines of work: prevention and early detection; diagnosis; therapy and registry; comprehensive and integrative care; health economics; and research and development.
In the prevention and early detection block, María Luz Couce, head of the Neonatology Service and director of the Unit of Diagnosis and Treatment of Congenital Metabolic Diseases at Hospital Clínico Universitario de Santiago de Compostela, has emphasized the importance of incorporating into the new Strategy progress in genetic studies and in assisted reproduction techniques.
With regard to preconception prevention, she has insisted on the desirability of implementing homogeneous preconception counseling circuits in Primary Care in all the autonomous communities, which include genetic counseling and access to preimplantation genetic diagnosis (DGP) when indicated.
Likewise, she has argued for expanding and harmonizing the service portfolio in order to move toward more uniform neonatal screening across the entire territory. To this end, she has pointed out the importance of continuously reviewing scientific evidence and updating screening programs, incorporating new technologies and genetic advances that make it possible to improve the early detection of these pathologies.